SULAZEPAM
UNII NZ779Q5S0W

Substance Identification & Data

This profile provides standardized clinical and technical data for Sulazepam, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NZ779Q5S0W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2898-13-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

NZ779Q5S0W

CAS Registry Number

2898-13-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SULAZEPAM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H13ClN2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MWGWTOPCKLQYEU-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C73210

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

17931

Unique identification number in the NCBI database of chemical substances.

INN ID

1728

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C=1(c2c(N(C)C(CN1)=S)ccc(c2)Cl)c3ccccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sulazepam. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.